Rocket VR Health Partners with Penn Medicine's Abramson Cancer Center to Study the Use of VR in Patients Undergoing Radiation Therapy
BOSTON, Aug. 18, 2022 /PRNewswire/ -- Rocket VR Health, a digital therapeutics company developing immersive therapy programs, is partnering with Penn Medicine's Abramson Cancer Center to explore the use of virtual reality (VR) technology in cancer patients undergoing radiation therapy.
- BOSTON, Aug. 18, 2022 /PRNewswire/ -- Rocket VR Health , a digital therapeutics company developing immersive therapy programs, is partnering with Penn Medicine's Abramson Cancer Center to explore the use of virtual reality (VR) technology in cancer patients undergoing radiation therapy.
- Rocket VR's immersive meditation program will be administered as part of a feasibility study with 25 patients prior to receiving daily treatments, utilizing the HTC VIVE Flow VR headset.
- The imagery and sounds experienced are designed to create an immersive environment by making use of mindfulness meditation in nature.
- Rocket VR Health is developing virtual reality digital therapeutics to address unmet mental health needs in cancer patients and survivors.